Related Experiment Video
Updated: Sep 21, 2025

09:45
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
8.5K
MIO: microRNA target analysis system for immuno-oncology
Pablo Monfort-Lanzas1,2, Raphael Gronauer1, Leonie Madersbacher1
1Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Bioinformatics (Oxford, England)
|June 1, 2022
Summary
Researchers developed MIO, a web platform, and miopy, a Python toolkit, to analyze microRNA and gene expression data for immuno-oncology. These tools aid in identifying biomarkers and therapeutic targets within the tumor microenvironment and immune response.
Area of Science:
- Computational biology
- Bioinformatics
- Immunology
Background:
- MicroRNAs play a crucial role in modulating the tumor microenvironment and immune responses.
- MicroRNAs are promising biomarkers and therapeutic targets in immuno-oncology.
- A lack of dedicated analysis tools hinders microRNA research in this field.
Purpose of the Study:
- To introduce MIO, a user-friendly web platform, and miopy, a Python toolkit.
- To provide integrated methods for analyzing bulk microRNA and gene expression data.
- To facilitate the identification of prognostic and predictive microRNA and gene interaction network biomarkers.
Main Methods:
- Integration of various visualization and analysis methods for microRNA and gene expression data.
- Implementation of regularized regression and survival analysis.
- Inclusion of 40 microRNA target prediction tools, curated immune signatures, and processed TCGA data with immune cell estimations and immunophenoscore.
Main Results:
- The MIO platform and miopy toolkit offer a comprehensive solution for microRNA and gene expression analysis in immuno-oncology.
- The tools enable the selection of prognostic and predictive biomarkers through integrated machine learning methods.
- Users can analyze custom data or utilize processed TCGA data with immune cell infiltration estimations.
Conclusions:
- MIO and miopy address the need for dedicated analysis tools in immuno-oncology research.
- These platforms empower researchers to explore microRNA functions and identify novel biomarkers.
- The integrated approach facilitates a deeper understanding of the interplay between microRNAs, the tumor microenvironment, and immune responses.

